Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Sleep cannabidiol:

Search results

Items: 1 to 20 of 108

1.

Cannabis-based products for pediatric epilepsy: A systematic review.

Elliott J, DeJean D, Clifford T, Coyle D, Potter BK, Skidmore B, Alexander C, Repetski AE, Shukla V, McCoy B, Wells GA.

Epilepsia. 2018 Dec 4. doi: 10.1111/epi.14608. [Epub ahead of print]

PMID:
30515765
2.

Exploring cannabis use by patients with multiple sclerosis in a state where cannabis is legal.

Weinkle L, Domen CH, Shelton I, Sillau S, Nair K, Alvarez E.

Mult Scler Relat Disord. 2018 Nov 20;27:383-390. doi: 10.1016/j.msard.2018.11.022. [Epub ahead of print]

PMID:
30502644
3.

Brief Report: Cannabidiol-Rich Cannabis in Children with Autism Spectrum Disorder and Severe Behavioral Problems-A Retrospective Feasibility Study.

Aran A, Cassuto H, Lubotzky A, Wattad N, Hazan E.

J Autism Dev Disord. 2018 Oct 31. doi: 10.1007/s10803-018-3808-2. [Epub ahead of print]

PMID:
30382443
4.

Cannabidiol affects circadian clock core complex and its regulation in microglia cells.

Lafaye G, Desterke C, Marulaz L, Benyamina A.

Addict Biol. 2018 Oct 11. doi: 10.1111/adb.12660. [Epub ahead of print]

PMID:
30307084
5.

Translational Investigation of the Therapeutic Potential of Cannabidiol (CBD): Toward a New Age.

Crippa JA, Guimarães FS, Campos AC, Zuardi AW.

Front Immunol. 2018 Sep 21;9:2009. doi: 10.3389/fimmu.2018.02009. eCollection 2018. Review.

6.

Cannabinoid Delivery Systems for Pain and Inflammation Treatment.

Bruni N, Della Pepa C, Oliaro-Bosso S, Pessione E, Gastaldi D, Dosio F.

Molecules. 2018 Sep 27;23(10). pii: E2478. doi: 10.3390/molecules23102478. Review.

PMID:
30262735
Free PMC Article
7.

Cannabidiol as a suggested candidate for treatment of autism spectrum disorder.

Poleg S, Golubchik P, Offen D, Weizman A.

Prog Neuropsychopharmacol Biol Psychiatry. 2019 Mar 8;89:90-96. doi: 10.1016/j.pnpbp.2018.08.030. Epub 2018 Aug 29. Review.

PMID:
30171992
8.

Dravet Syndrome: A Sodium Channel Interneuronopathy.

Catterall WA.

Curr Opin Physiol. 2018 Apr;2:42-50. doi: 10.1016/j.cophys.2017.12.007. Epub 2017 Dec 23.

PMID:
30123852
9.

Cannabis for pediatric epilepsy: protocol for a living systematic review.

Elliott J, DeJean D, Clifford T, Coyle D, Potter B, Skidmore B, Alexander C, Repetski AE, McCoy B, Wells GA.

Syst Rev. 2018 Jul 18;7(1):95. doi: 10.1186/s13643-018-0761-2.

10.

A Cross-Sectional Study of Cannabidiol Users.

Corroon J, Phillips JA.

Cannabis Cannabinoid Res. 2018 Jul 1;3(1):152-161. doi: 10.1089/can.2018.0006. eCollection 2018.

11.

Effectiveness of Raw, Natural Medical Cannabis Flower for Treating Insomnia under Naturalistic Conditions.

Vigil JM, Stith SS, Diviant JP, Brockelman F, Keeling K, Hall B.

Medicines (Basel). 2018 Jul 11;5(3). pii: E75. doi: 10.3390/medicines5030075.

12.

Systemic Injections of Cannabidiol Enhance Acetylcholine Levels from Basal Forebrain in Rats.

Murillo-Rodríguez E, Arankowsky-Sandoval G, Rocha NB, Peniche-Amante R, Veras AB, Machado S, Budde H.

Neurochem Res. 2018 Jun 6. doi: 10.1007/s11064-018-2565-0. [Epub ahead of print]

PMID:
29876791
13.

Medical Cannabis for Pediatric Moderate to Severe Complex Motor Disorders.

Libzon S, Schleider LB, Saban N, Levit L, Tamari Y, Linder I, Lerman-Sagie T, Blumkin L.

J Child Neurol. 2018 Aug;33(9):565-571. doi: 10.1177/0883073818773028. Epub 2018 May 16.

PMID:
29766748
14.

No Acute Effects of Cannabidiol on the Sleep-Wake Cycle of Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study.

Linares IMP, Guimaraes FS, Eckeli A, Crippa ACS, Zuardi AW, Souza JDS, Hallak JE, Crippa JAS.

Front Pharmacol. 2018 Apr 5;9:315. doi: 10.3389/fphar.2018.00315. eCollection 2018.

15.

Treatment Strategies for Dravet Syndrome.

Knupp KG, Wirrell EC.

CNS Drugs. 2018 Apr;32(4):335-350. doi: 10.1007/s40263-018-0511-y. Review. Erratum in: CNS Drugs. 2018 Aug;32(8):783.

PMID:
29594870
16.

Cannabis-based medicines for chronic neuropathic pain in adults.

Mücke M, Phillips T, Radbruch L, Petzke F, Häuser W.

Cochrane Database Syst Rev. 2018 Mar 7;3:CD012182. doi: 10.1002/14651858.CD012182.pub2. Review.

PMID:
29513392
17.

Cannabinoids in the Treatment of Epilepsy: Hard Evidence at Last?

Perucca E.

J Epilepsy Res. 2017 Dec 31;7(2):61-76. doi: 10.14581/jer.17012. eCollection 2017 Dec. Review.

18.

Efficacy and safety of cannabis for treating children with refractory epilepsy.

Neale M.

Nurs Child Young People. 2017 Sep 11;29(7):32-37. doi: 10.7748/ncyp.2017.e907. Review.

PMID:
29115760
19.

A randomised controlled cross-over double-blind pilot study protocol on THC:CBD oromucosal spray efficacy as an add-on therapy for post-stroke spasticity.

Marinelli L, Balestrino M, Mori L, Puce L, Rosa GM, Giorello L, Currà A, Fattapposta F, Serrati C, Gandolfo C, Abbruzzese G, Trompetto C.

BMJ Open. 2017 Sep 7;7(9):e016843. doi: 10.1136/bmjopen-2017-016843.

20.

Cannabidiol inhibits priming-induced reinstatement of methamphetamine in REM sleep deprived rats.

Karimi-Haghighi S, Haghparast A.

Prog Neuropsychopharmacol Biol Psychiatry. 2018 Mar 2;82:307-313. doi: 10.1016/j.pnpbp.2017.08.022. Epub 2017 Sep 1.

PMID:
28870635

Supplemental Content

Loading ...
Support Center